379
Views
12
CrossRef citations to date
0
Altmetric
Papers

Association between arsenic exposure and thyroid function: data from NHANES 2007–2010

Pages 101-129 | Received 17 Nov 2014, Accepted 05 May 2015, Published online: 08 Jul 2015

References

  • Amster ED, Cho JI, Christiani D. 2011. Urine arsenic concentration and obstructive pulmonary disease in the U.S. Population. J Toxicol Environ Health A. 74:716–727. doi:10.1080/15287394.2011.556060.
  • Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL. 2006. Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ Health Perspect. 114:1865–1871.
  • Bodwell JE, Gosse JA, Nomikos AP, Hamilton JW. 2006. Arsenic disruption of steroid receptor gene activation: complex dose−response effects are shared by several steroid receptors. Chem Res Toxicol. 19:1619–1629.10.1021/tx060122q
  • Boggio A, Muzio F, Fiscella M, Sommariva D, Branchi A. 2014. Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women? Intern Emerg Med. ( PubMed ID 22203234). 9:51–57. doi: 10.1007/s11739-011-0743z.
  • Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Wang YH, Chen CJ. 2010. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from Northeastern Taiwan. Cancer Epidemiol Biomarkers Prev. 19:101–110.10.1158/1055-9965.EPI-09-0333
  • Chen Y, Graziano JH, Parvez F, Liu M, Slakovich V, Kalra T, Argos M, Islam T, Ahmed A, Rakibuz-Zaman M, et al. 2011. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. 342:d2431. doi:10.1136/bmj.d2431.
  • Ciarrocca M, Tomei F, Caciari T, Cetica C, Andrè JC, Fiaschetti M, Schifano MP, Scala B, Scimitto L, Tomei G, Sancini A. 2012. Exposure to arsenic in urban and rural areas and effects on thyroid hormones. Inhal Toxicol. 24:589–598. doi:10.3109/08958378.2012.703251.
  • Dauphiné DC, Ferreccio C, Guntur S, Yuan Y, Hammond SK, Balmes J, Smith AH, Steinmaus C. 2011. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int Arch Occup Environ Health. 84:591–600.10.1007/s00420-010-0591-6
  • Davey JC, Bodwell JE, Gosse JA, Hamilton JW. 2007. Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci. 98:75–86.10.1093/toxsci/kfm013
  • Davey JC, Nomikos AP, Wungjiranium M, Shermna JR, Ingran L, Batki C, Laiviere JP, Hamilton JW. 2008. Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis. Environ Health Perspect. 116:165–172.
  • Eales JG, Shostak S. 1985. Free T4 and T3 in relation to total hormone, free hormone indices, and protein in plasma of rainbow trout and arctic charr. Gen Comp Endocrinol. 58:291–302.10.1016/0016-6480(85)90345-4
  • Ferreccio C, Yuan Y, Calle J, Benítez H, Parra RL, Acevedo J, Smith AH, Liaw J, Steinmaus C. 2013. Arsenic, tobacco smoke, and occupation. Epidemiology. 24:898–905.10.1097/EDE.0b013e31829e3e03
  • Forti P, Olivelli V, Rietti E, Maltoni B, Pirazzoli G, Gatti R, Gioia MG, Ravaglia G. 2012. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. Gerontology. 58:41–49.10.1159/000324522
  • Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, Nanchen D, den Elzen WP, Balmer P, Luben RN, et al. 2012. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 126:1040–1049.10.1161/CIRCULATIONAHA.112.096024
  • Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. 2002. Serum TSH, T 4, and thyroid antibodies in the United States Population (1988–1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 87:489–499.10.1210/jcem.87.2.8182
  • Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. 2011. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 123:305–332.10.1093/toxsci/kfr184
  • Jain RB. 2013a. Association between thyroid profile and perfluoroalkyl acids: data from NHNAES 2007–2008. Environmental Research. 126:51–59.10.1016/j.envres.2013.08.006
  • Jain RB. 2013b. Effect of smoking and caffeine consumption on polybrominated diphenyl ethers (PBDE) and polybrominated biphenyls (PBB). J Toxicol Environ Health A. 76:515–532.10.1080/15287394.2013.785348
  • Jain RB. 2014. Association between thyroid function and selected organochlorine pesticides: data from NHANES 2001–2002. Sci Total Environment. 466–467:706–715.10.1016/j.scitotenv.2013.07.087
  • Jain RB, Wang RY. 2011. Association of caffeine consumption and smoking status with the serum concentrations of polychlorinated biphenyls, dioxins, and furans in the General U.S. Population: NHANES 2003–2004. J Toxicol Environ Health A. 74:1225–1239.10.1080/15287394.2011.587105
  • Kelly G. 2000. Peripheral metabolism of thyroid hormones: a review. Altern Med Rev. 5:306–333.
  • Khlifi R, Olmedo P, Gil F, Feki-Tounsi M, Hammami B, Rebai A, Hamza-Chaffai A. 2014. Risk of laryngeal and nasopharyngeal cancer associated with arsenic and cadmium in the Tunisian population. Environ Sci Pollut Res Int. 21:2032–2042.
  • Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. 2004. Laboratory reference values. New Eng J Med. 351:1548–1563.
  • Miller MD, Crofton KM, Rice DC, Zoeller RT. 2009. Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect. 117:1033–1041.10.1289/ehp.0800247
  • Moon KA, Guallar E, Umans JG, Devereux RB, Best LG, Francesconi KA, Goessler W, Pollak J, Silbergeld EK, Howard BV, Navas-Acien A. 2013. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease: a prospective cohort study. Ann Intern Med. 159:649–659. doi:10.7326/0003-4819-159-10-201311190-00719.
  • Mumford JL, Wu K, Xia Y, Kwok R, Yang Z, Foster J, Sanders WE. 2007. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ Health Perspect. 115:690–694.10.1289/ehp.9686
  • Palaneeswari MS, Rajan PM, Silambanan S, Jothimalar. 2013. Blood arsenic and cadmium concentrations in end-stage renal disease patients who were on maintenance haemodialysis. J Clin Diagn Res. 7:809–813. doi:10.7860/JCDR/2013/5351.2945.
  • Pan WC, Seow WJ, Kile ML, Hoffman EB, Quamruzzaman Q, Rahman M, Mahiuddin G, Mostofa G, Lu Q, Christiani DC. 2013. Association of low to moderate levels of arsenic exposure with risk of type 2 diabetes in Bangladesh. Am J Epidemiol. 178:1563–1570. doi:10.1093/aje/kwt195.
  • Parvez F, Chen Y, Brandt-Rauf PW, Slavkovich V, Islam T, Ahmed A, Argos M, Hassan R, Yunus M, Haque SE. 2010. A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the health effects of arsenic longitudinal study (HEALS). Thorax. 65:528–533.10.1136/thx.2009.119347
  • Parvez F, Chen Y, Yunus M, Olopade C, Segers S, Slavkovich V, Argos M, Hasan R, Ahmed A, Islam T, et al. 2013. Arsenic exposure and impaired lung function. Findings from a large population-based prospective cohort study. Am J Respir Crit Care Med. 188:813–819. doi:10.1164/rccm.201212-2282OC.
  • Putila JL, Guo NL. 2011. Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS ONE. 6:e25886. doi:10.1371/journal.pone.0025886.
  • Rokadia HK, Agarwal S. 2012. Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey (NHANES). Lung. 190:283–290. doi:10.1007/s00408-012-9374-z.
  • Sawada N, Iwasaki M, Inoue M, Takachi R, Sasazuki S, Yamaji T, Shimazu T, Tsugane S. 2013. Dietary arsenic intake and subsequent risk of cancer: the Japan public health center-based (JPHC) prospective study. Cancer Causes Control. 24:1403–1415. doi:10.1007/s10552-013-0220-2.
  • Steinmaus C, Yuan Y, Liaw J, Smith AH. 2009. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus. A reanalysis. Epidemiology. 20:807–815.10.1097/EDE.0b013e3181b0fd29
  • Tseng CH, Chong CK, Chen CJ, Tai TY. 1996. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis. 120:125–133.10.1016/0021-9150(95)05693-9
  • Turyk ME, Anderson HA, Persky VW. 2007. Relationships of thyroid hormones with polychlorinated biphenyls, dioxins, furans, and DDE in adults. Environ Health Perspect. 115:1197–1203.10.1289/ehp.10179
  • Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, Slavkovich V, LoIacono NJ, Cheng Z., Hussain, I., et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 112:1329–1333.10.1289/ehp.6964
  • Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, van Geen A, Slavkovich V, Loiacono NJ, Levy D, et al. 2007. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect. 115:285–289.
  • Watanabe C, Inaoka T, Matsui T, Ishigaki K, Murayama N, Ohtsuka R. 2003. Effects of arsenic on younger generations. J Environ Sci Health A. 38:129–139.10.1081/ESE-120016885
  • Watanabe C, Matsui T, Inaoka T, Kadono T, Miyazaki K, Bae MJ, Ono T, Ohtsuka R, Mozammel Haque Bokul AT. 2007. Dermatological and nutritional/growth effects among children living in arsenic-contaminated communities in rural Bangladesh. J Environ Sci Health A. 42:1835–1841.10.1080/10934520701566850
  • Wei Y, Zhu J, Nguyen A. 2014. Rice consumption and urinary concentrations of arsenic in US adults. Int J Enviorn Health Res. 24:459–470. doi:10.1080/09603123.2013.857393.
  • WHO. 2007. Iodine deficiency in Europe: a continuing public health problem. In: Andersson M, de Benoist B, Darnton-Hill I, Delange F, editors. [cited 2013 Jun 25]. Available from: http://www.who.int/nutrition/publications/VMNIS_Iodine_deficiency_in_Europe.pdf.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.